• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

登革热的卫生经济学:系统文献综述与专家小组评估

Health economics of dengue: a systematic literature review and expert panel's assessment.

作者信息

Beatty Mark E, Beutels Philippe, Meltzer Martin I, Shepard Donald S, Hombach Joachim, Hutubessy Raymond, Dessis Damien, Coudeville Laurent, Dervaux Benoit, Wichmann Ole, Margolis Harold S, Kuritsky Joel N

机构信息

Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Kwanak-gu, Seoul, Republic of Korea.

出版信息

Am J Trop Med Hyg. 2011 Mar;84(3):473-88. doi: 10.4269/ajtmh.2011.10-0521.

DOI:10.4269/ajtmh.2011.10-0521
PMID:21363989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3042827/
Abstract

Dengue vaccines are currently in development and policymakers need appropriate economic studies to determine their potential financial and public health impact. We searched five databases (PubMed, EMBASE, LILAC, EconLit, and WHOLIS) to identify health economics studies of dengue. Forty-three manuscripts were identified that provided primary data: 32 report economic burden of dengue and nine are comparative economic analyses assessing various interventions. The remaining two were a willingness-to-pay study and a policymaker survey. An expert panel reviewed the existing dengue economic literature and recommended future research to fill information gaps. Although dengue is an important vector-borne disease, the economic literature is relatively sparse and results have often been conflicting because of use of inconsistent assumptions. Health economic research specific to dengue is urgently needed to ensure informed decision making on the various options for controlling and preventing this disease.

摘要

登革热疫苗目前正在研发中,政策制定者需要进行适当的经济研究,以确定其潜在的财政和公共卫生影响。我们检索了五个数据库(PubMed、EMBASE、LILAC、EconLit和WHOLIS),以查找登革热的卫生经济学研究。共识别出43篇提供原始数据的手稿:32篇报告了登革热的经济负担,9篇是评估各种干预措施的比较经济分析。其余两篇是支付意愿研究和政策制定者调查。一个专家小组审查了现有的登革热经济文献,并建议开展未来研究以填补信息空白。尽管登革热是一种重要的媒介传播疾病,但经济文献相对较少,而且由于假设不一致,结果往往相互矛盾。迫切需要开展针对登革热的卫生经济研究,以确保在控制和预防这种疾病的各种选择上做出明智的决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f79/3042827/d5aae132c2cb/tropmed-84-473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f79/3042827/d5aae132c2cb/tropmed-84-473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f79/3042827/d5aae132c2cb/tropmed-84-473-g001.jpg

相似文献

1
Health economics of dengue: a systematic literature review and expert panel's assessment.登革热的卫生经济学:系统文献综述与专家小组评估
Am J Trop Med Hyg. 2011 Mar;84(3):473-88. doi: 10.4269/ajtmh.2011.10-0521.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
The economic promise of developing and implementing dengue vaccines: Evidence from a systematic review.开发和应用登革热疫苗的经济前景:一项系统综述的证据
Vaccine. 2016 Dec 7;34(50):6133-6147. doi: 10.1016/j.vaccine.2016.10.037. Epub 2016 Oct 31.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
6
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.在没有明显临床指征的患者和常见合并症患者亚组中,在择期手术前常规检测全血细胞计数、电解质和尿素以及肺功能测试的价值:对临床和成本效益文献的系统评价。
Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500.
7
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
8
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.多奈哌齐、加兰他敏、利伐斯的明和美金刚治疗阿尔茨海默病的有效性和成本效果(技术评估第 111 号回顾):系统评价和经济模型。
Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210.
9
The use of Open Dialogue in Trauma Informed Care services for mental health consumers and their family networks: A scoping review.创伤知情护理服务中使用开放对话模式为心理健康消费者及其家庭网络提供服务:范围综述。
J Psychiatr Ment Health Nurs. 2024 Aug;31(4):681-698. doi: 10.1111/jpm.13023. Epub 2024 Jan 17.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
Proteomics Analysis of Peripheral Blood Mononuclear Cells from Patients in Early Dengue Infection Reveals Potential Markers of Subsequent Fluid Leakage.登革热早期感染患者外周血单个核细胞的蛋白质组学分析揭示了随后发生体液渗漏的潜在标志物。
Viruses. 2025 May 31;17(6):805. doi: 10.3390/v17060805.
2
Development of a rapid point-of-care dengue virus type 2 infection diagnostic assay using recombinase polymerase amplification and lateral flow device.利用重组酶聚合酶扩增和侧向流动装置开发一种快速即时检测2型登革热病毒感染的诊断方法。
Front Cell Infect Microbiol. 2025 May 14;15:1578549. doi: 10.3389/fcimb.2025.1578549. eCollection 2025.
3

本文引用的文献

1
Reducing costs and operational constraints of dengue vector control by targeting productive breeding places: a multi-country non-inferiority cluster randomized trial.通过针对有效繁殖地降低登革热病媒控制的成本和操作限制:一项多国非劣效性整群随机试验
Trop Med Int Health. 2009 Sep;14(9):1143-53. doi: 10.1111/j.1365-3156.2009.02341.x. Epub 2009 Jul 14.
2
Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study.柬埔寨农村家庭登革热及其他发热性疾病的成本:一项基于社区的前瞻性病例对照研究。
BMC Public Health. 2009 May 27;9:155. doi: 10.1186/1471-2458-9-155.
3
Assessing the effect of () (Linnaeus, 1762) control based on machine learning for predicting the spatiotemporal distribution of eggs in ovitraps.
基于机器学习评估()(林奈,1762年)控制对预测诱蚊产卵器中蚊卵时空分布的效果。
Dialogues Health. 2022 Feb 9;1:100003. doi: 10.1016/j.dialog.2022.100003. eCollection 2022 Dec.
4
Host immunity and vaccine development against Dengue virus.针对登革病毒的宿主免疫与疫苗研发
Infect Med (Beijing). 2022 Feb 6;1(1):50-58. doi: 10.1016/j.imj.2021.12.003. eCollection 2022 Mar.
5
Development in the Inhibition of Dengue Proteases as Drug Targets.登革热蛋白酶抑制剂的研究进展及其作为药物靶点的潜力
Curr Med Chem. 2024;31(16):2195-2233. doi: 10.2174/0929867331666230918110144.
6
Dengue Incidence Trends and Its Burden in Major Endemic Regions from 1990 to 2019.1990年至2019年主要流行地区的登革热发病率趋势及其负担
Trop Med Infect Dis. 2022 Aug 12;7(8):180. doi: 10.3390/tropicalmed7080180.
7
Intra-Host Diversity of Dengue Virus in Mosquito Vectors.蚊媒中登革病毒的宿主内多样性。
Front Cell Infect Microbiol. 2022 Jun 22;12:888804. doi: 10.3389/fcimb.2022.888804. eCollection 2022.
8
Effects of COVID-19 Non-Pharmacological Interventions on Dengue Infection: A Systematic Review and Meta-Analysis.COVID-19 非药物干预措施对登革热感染的影响:系统评价和荟萃分析。
Front Cell Infect Microbiol. 2022 May 19;12:892508. doi: 10.3389/fcimb.2022.892508. eCollection 2022.
9
ArboAlvo: stratification method for territorial receptivity to urban arboviruses.ArboAlvo:城市虫媒病毒地域易感性分层方法。
Rev Saude Publica. 2022 May 27;56:39. doi: 10.11606/s1518-8787.2022056003546. eCollection 2022.
10
Modified mRNA-LNP Vaccines Confer Protection against Experimental DENV-2 Infection in Mice.改良的mRNA-LNP疫苗可保护小鼠免受实验性登革热病毒2型感染。
Mol Ther Methods Clin Dev. 2020 Jul 21;18:702-712. doi: 10.1016/j.omtm.2020.07.013. eCollection 2020 Sep 11.
Cost of dengue cases in eight countries in the Americas and Asia: a prospective study.
美洲和亚洲八个国家登革热病例的成本:一项前瞻性研究。
Am J Trop Med Hyg. 2009 May;80(5):846-55.
4
Disability adjusted life years lost to dengue in Brazil.巴西因登革热损失的伤残调整生命年。
Trop Med Int Health. 2009 Feb;14(2):237-46. doi: 10.1111/j.1365-3156.2008.02203.x. Epub 2009 Jan 20.
5
[Cost-benefit analysis of vector control in areas of potential dengue transmission].
Rev Panam Salud Publica. 2008 Aug;24(2):113-9. doi: 10.1590/s1020-49892008000800005.
6
Funding of drugs: do vaccines warrant a different approach?药物资金:疫苗是否需要不同的方法?
Lancet Infect Dis. 2008 Nov;8(11):727-33. doi: 10.1016/S1473-3099(08)70258-5.
7
Historical analysis of the economic cost of dengue in Australia.澳大利亚登革热经济成本的历史分析。
J Vector Borne Dis. 2008 Sep;45(3):245-8.
8
Clinical characteristics and national economic cost of the 2005 dengue epidemic in Panama.2005年巴拿马登革热疫情的临床特征及国家经济成本
Am J Trop Med Hyg. 2008 Sep;79(3):364-71.
9
Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects.在初次接触或黄病毒致敏的受试者中,嵌合四价登革热疫苗诱导的细胞介导免疫。
Vaccine. 2008 Oct 23;26(45):5712-21. doi: 10.1016/j.vaccine.2008.08.019. Epub 2008 Aug 30.
10
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults.三价减毒活登革热疫苗在未感染黄病毒的成年人中的2期临床试验。 (注:原文是tetravalent,译文按正确内容翻译为“四价”,但你提供的英文原文可能有误,正常应为四价,而非三价)
Hum Vaccin. 2009 Jan-Feb;5(1):33-40. doi: 10.4161/hv.5.1.6348. Epub 2009 Jan 27.